GM3NPhAc conjugates 1a and 2a and the HSA conjugate of GM3 were previously prepared by our laboratory.
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GM3NPhAc conjugates 1a and 2a and the HSA conjugate of GM3 were previously prepared by our laboratory. General procedure for the synthesis of compounds 7b-e. Compound 6 (30 mg, 0.025 mmol) was dissolved in 0.5 N aq. NaOH (2.0 mL), and the solution was stirred at rt for 10 h. After neutralization and condensation under reduced pressure, the crude product was directly used for the acylation. To a solution of the resultant amine (20 mg, 0.03 mmol) in 2.5 mL of MeOH and 0.5 mL of NaOH (0.5 N) was added 0.1 mL of an acyl anhydride dropwise in an ice-water bath. After the reaction is finished (in 6 h) as indicated by TLC, the mixture was condensed under reduced pressure. The residue was purified on a Biogel P-2 column with H 2 O as the eluent. Fractions containing the expected product were combined and freeze-dried to afford compound 7b-e after lyophilization as a white solid.
2-Azidoethyl (Methyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-trifluoroacetamido-D-glycero-α-D-

galacto-non-2-ulopyranosylonate)-(2→3)-(2,6-di-O-acetyl-β-D-galactopyranosyl)-(1→4)-2,3,6-
tri-O-acetyl-D-glucopyranoside (5)
.
N-{2-O-[(Methyl
N-{2-O-{[3,5-Dideoxy-5-(p-methylphenylacetamido)-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-
Pentenamide (7b). 
N-{2-O-{[3,5-Dideoxy-5-(p-methoxyphenylacetamido)-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Pentenamide (7c
N-{2-O-{[5-(p-Acetophenylacetamido)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Pentenamide (7d
S-4
Supplementary
The resultant solutions were allowed to warm to rt over a period of 1 h and stand for another 1 h before they were condensed in vacuum. The crude products were purified by a Biogel P-2 column using distilled water as the eluent to give aldehydes 8b-e after lyophilization as white solids, which were used in the following conjugation reactions without further purification. 
N-{2-O-{[3,5-Dideoxy-5-(p-methylphenylacetamido)-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Oxobutanamide (8b
N-{2-O-{[3,5-Dideoxy-5-(p-methoxyphenylacetamido)-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Oxobutanamide (8c
N-{2-O-{[5-(p-Acetophenylacetamido)-3,5-Dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Oxo-butanamide (8d).
N-{2-O-{[5-(p-Chlorophenylacetamido)-3,5-Dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid]-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranosyl}-ethyl} 4-Oxobutanamide (8e).
3''e), 2. Procedure for the coupling between 8b-e and KLH or HSA. The solutions of 8b-e (7 mg), KLH or HSA (7 mg), and NaBH 3 CN (7 mg) in 0.1 M aq. NaHCO 3 (0.1 mL, pH 7.5-8.0) were allowed to stand at rt in the dark for 4 days with occasional shaking. The reaction mixtures were then purified by a Biogel A 0.5 column using 0.1 M phosphate buffered saline (PBS) buffer (I = 0.1, pH =7.8) as the eluent. The fractions containing the glycoconjugates, characterized by bicinchoninic acid (BCA) assay for proteins, were combined and dialyzed against distilled water for 2 days. They were lyophilized to
give a white powder of the expected glycoconjugates 1b-e and 2b-e (~ 6-7 mg).
Analysis of the carbohydrate loading levels of the glycoconjugates 1b-e and 2b-e. 2 The solution of an exactly weighed glycoconjugate (0.35-0.6 mg) in distilled water (1.0 mL) was mixed with the resorcinol reagent (2.0 mL) and the mixture was heated in a boiling water bath for 30 min. After it was cooled to rt, was added an extraction solution (1-butanol acetate and 1-butanol, 85:15 v/v, 3.0 mL).
The mixture was shaken vigorously before it was allowed to stand still for ca. 10 min to allow the organic layer to separate well from the inorganic layer. The organic layer was transferred to a 1.0-cm cuvette, and its absorbance at 580 nm was determined by an UV-Vis spectrometer, using a blank extraction solution as the control. The sialic acid content of the glycoconjugates was determined against a calibration curve created with the solution of an individual standard NeuNPhAc derivative analyzed under the same condition. The carbohydrate loading of each glycoconjugate was calculated according to the following equation.
Immunization of Mouse.
A total of 0.1 mL of the emulsion of 1a-e (containing 3 g of carbohydrate antigen) and Titermax Gold adjuvant (Sigma Chemical, St. Louis, MO) were intramuscularly injected to each group of five female C57BL/6 mice at the age of 6-8 weeks (Jackson Laboratories, Bar Harbor, ME) on day 0, 14, 21 and 28, respectively. The mice were bled prior to the initial immunization on day -1 and after immunization on day 27 and day 37. Blood samples collected at each time point were clotted to obtain antisera and stored at -80 o C before assays.
Enzyme-Linked Immunosorbent Assay (ELISA).
ELISA plates were treated respectively with 100 µL solution of conjugates 2a-e and GM3-HSA (2 µg/mL) in the coating buffer (0.1 M bicarbonate, pH
S-6
9.6) overnight at 4 °C, followed by washing 3 times with PBS containing 0.05% Tween-20 (PBST).
Individual or pooled antisera from mice inoculated with 1a-e were diluted 1:300 to 1:72900 in serial half-log dilutions in PBS and incubated for 2 h at 37 
